Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Browsing: BioTech
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed a Phase I clinical trial on…
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism…
Significantly Boosting Market Penetration and Driving Valuation Reassessment On November 28, the National Healthcare Security Administration (NHSA) and the Ministry…
Marking Another Milestone in Commercialization Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food…
– Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients Everest Medicines (HKG: 1952, Everest, or the…
The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li,…
– Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the…
Enhancing the Quality of Life for All, Commiting to Investing in Technology Upgrades, and Developing Pharmaceutical and Healthcare Product Innovations…
– Published in “Kidney 360” Magazine Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the…
– ACROMETA seeks to unlock value from its disposal of Life Science Incubator Holdings Pte. Ltd. following a strategic review.…
Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Everest Medicines (HKG: 1952) closed today with a 20.46% increase, hitting a high of HKD 28.6. The company’s stock price…
ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described…
– VLP-Polio Expected to Accelerate Development and Fill the Gap. CanSino Biologics Inc. (CanSinoBIO or the Company) has announced a…
GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating…
– Collaboration to leverage AbbVie’s eye care expertise and Ripple’s innovative drug delivery platform to develop next-generation sustained release drug…
Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development…
– Dorzagliatin (trade name: HuaTangNing, world’s first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic…
– Meningococcal Vaccines Drive Growth and Accelerate Collaboration and Internationalization CanSino Biologics Inc. (CanSinoBIO) today disclosed its performance report for…